The learning curve for robot-assisted distal pancreatectomy: a single-center experience of 301 cases [0.03%]
机器人辅助远端胰腺切除术的学习曲线:单中心301例手术的经验
Qiang Xu,Tiantong Liu,Xi Zou et al.
Qiang Xu et al.
Robotic distal pancreatectomy (RDP) has become a routine procedure in many pancreatic centers. This study aimed to describe a single-center experience with RDP since the first case, identify the learning curves of operation time and complic...
A note on error bars as a graphical representation of the variability of data in biomedical research: Choosing between standard deviation and standard error of the mean [0.03%]
谈生物医学研究中用误差线图表示数据变异性的注意事项:标准差与均数标准误的选择
Li Tang,Hui Zhang,Bo Zhang
Li Tang
Standard deviation and standard error of the mean have been applied widely as error bars in scientific plots. Unfortunately, there is no universally accepted principle addressing which of these two measures should be used. Here we seek to f...
Rui Kang,Daolin Tang
Rui Kang
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of exocrine pancreatic cancer with a 9% five-year survival rate. High mobility group box 1 (HMGB1) is a nuclear protein that can act as a DNA chaperone in the sustainment of ch...
The Achilles' Heel of Pancreatic Cancer: Targeting pancreatic cancer's unique immunologic characteristics and metabolic dependencies in clinical trials [0.03%]
胰腺癌的阿喀琉斯之踵——临床试验针对胰腺癌独特的免疫学特点和代谢依赖性
Despina Siolas,Christy Morrissey,Paul Eliezer Oberstein
Despina Siolas
Total pancreatectomy with islet autotransplantation in diabetic and pre-diabetic patients with intractable chronic pancreatitis [0.03%]
慢性胰腺炎合并糖尿病及前期糖尿病患者总胰腺切除及胰岛自体移植术
Piotr J Bachul,Damian J Grybowski,Roi Anteby et al.
Piotr J Bachul et al.
Total pancreatectomy with islet autotransplantation (TPIAT) is an effective treatment option for non-diabetic patients with intractable chronic pancreatitis. The outcome and potential benefits for pre-diabetic and diabetic patients are less...
Andrew Fesler,Jingfang Ju
Andrew Fesler
Despite extensive research efforts on diagnosis and treatment, pancreatic ductal adenocarcinoma (PDAC) remains a devastating disease and the third leading cause of cancer-related death in the United States. Resistance to current therapeutic...